The Lyn/RUVBL1 Complex Promotes Colorectal Cancer Liver Metastasis by Regulating Arachidonic Acid Metabolism Through Chromatin Remodeling
Advanced Science · 2025-02 · 12 (5)
DOI: 10.1002/advs.202406562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.12.2024. Verfasst von Zhenyu Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Hospital of Dalian Medical University, Dalian, 116023, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Chromatin Assembly and Disassembly, Arachidonic Acid. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Liver metastasis is a common cause of death in colorectal cancer (CRC) patients, but epigenetic remodeling and metabolic reprogramming for CRC liver metastasis remain unclear. The study revealed that the Lyn/RUVBL1 complex is highly expressed in CRC and is closely correlated with liver metastasis. On the one hand, ATAC‐seq and HiCut suggested that Lyn/RUVBL1 regulates the expression of TRIB3 through the POL II‐mediated chromatin conformation of TRIB3 and thus the expression of β‐catenin. This promotes the proliferation and migration of CRC through β‐catenin‐mediated upregulation of MMP9 and VEGF. On the other hand, metabolomics revealed that Lyn/RUVBL1 regulates the expression of PGE2 through the enzyme COX2, thereby promoting arachidonic acid (AA) metabolism. CUT‐Tag showed that Lyn/RUVBL1 silencing reduces the H3K27ac level in the COX2 promoter. Then, it is found that COX2 is regulated by the transcription factor FOXA1. Lyn/RUVBL1 modulates AA metabolism by regulating the chromatin accessibility of FOXA1. AA metabolism promotes the metastasis of CRC by affecting β‐catenin nuclear translocation and upregulating MMP9 and VEGF. These findings suggest that the Lyn/RUVBL1 complex mediates epigenetic remodeling to regulate the metabolic reprogramming of AA, highlighting its role in promoting the metastasis of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Second Hospital of Dalian Medical University, Dalian, 116023, China.
- Department of Clinical Biochemistry, College of Laoratory Medicine, Dalian Medical University, Dalian, 116044, China.
ORCID-Profile: Shuangyi Ren
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z., Gao, Y., Qian, Y., Wei, B., Jiang, K., Sun, Z., Zhang, F., Yang, M., Baldi, S., Yu, X., Zuo, Y., & Ren, S. (2025). The Lyn/RUVBL1 Complex Promotes Colorectal Cancer Liver Metastasis by Regulating Arachidonic Acid Metabolism Through Chromatin Remodeling. Advanced Science, 12(5). https://doi.org/10.1002/advs.202406562
Vancouver
Zhang Z, Gao Y, Qian Y, Wei B, Jiang K, Sun Z, et al. The Lyn/RUVBL1 Complex Promotes Colorectal Cancer Liver Metastasis by Regulating Arachidonic Acid Metabolism Through Chromatin Remodeling. Advanced Science. 2025;12(5). doi:10.1002/advs.202406562
BibTeX
@article{Zhang2025,
author = {Zhang, Zhenyu and Gao, Yina and Qian, Yuanyuan and Wei, Bowen and Jiang, Kexin and Sun, Zhiwei and Zhang, Feifan and Yang, Mingming and Baldi, Salem and Yu, Xiaoqi and Zuo, Yunfei and Ren, Shuangyi},
title = {The Lyn/RUVBL1 Complex Promotes Colorectal Cancer Liver Metastasis by Regulating Arachidonic Acid Metabolism Through Chromatin Remodeling},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {5},
doi = {10.1002/advs.202406562}
}
EUVIMED